Companies: 10,795·Total market cap: $144.5T
ResMed Inc.

ResMed Inc.

RMDNYSEHealthcare● Active
$193.14
$-2.90(-1.48%)
Market Cap$28.0B
P/E Ratio
52W High$293.81
52W Low$180.27
Overview

ResMed Inc. (RMD) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · RMD · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-062024-062023-062022-062021-06
Operating Activities
Net Income$1.40B$1.02B$0.90B$0.78B$0.47B
Depreciation & Amort.$0.24B$0.22B$0.20B$0.19B$0.19B
Stock-Based Comp.$0.09B$0.08B$0.07B$0.07B$0.06B
Change in Working Capital$0.02B$0.04B($0.46B)($0.71B)$0.00B
Net Cash from Operations$1.75B$1.40B$0.69B$0.35B$0.74B
Investing Activities
Capital Expenditure($0.09B)($0.11B)($0.13B)($0.16B)($0.12B)
Purchases of Investments($0.01B)($0.02B)($0.03B)($0.02B)($0.02B)
Sales of Investments$0.00B$0.00B$0.00B$0.01B$0.00B
Net Cash from Investing($0.20B)($0.27B)($1.16B)($0.23B)($0.16B)
Financing Activities
Common Stock Repurchased($0.30B)($0.15B)$0.00B$0.00B$0.00B
Dividends Paid($0.31B)($0.28B)($0.26B)($0.25B)($0.23B)
Debt Issued / Repaid($0.04B)($0.73B)$0.67B$0.12B($0.52B)
Net Cash from Financing($0.61B)($1.12B)$0.42B($0.13B)($0.76B)
Free Cash Flow
Free Cash Flow$1.66B$1.29B$0.56B$0.20B$0.62B
FCF Margin %(computed)32.29%27.46%13.24%5.45%19.39%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more ResMed Inc. data

About ResMed Inc. (RMD) Cash Flow Statement

ResMed Inc. generated operating cash flow of $1.75B and free cash flow of $1.66B for 2025 — a FCF margin of 32.29%. Capital expenditure was ($0.09B).

Frequently asked questions

RMD · 4 questions

ResMed Inc. generated free cash flow of $1.66B for 2025, up 29.2% year-over-year.

RMD free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10